These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 11880049)
1. Basis for antifolate action and resistance in malaria. Yuthavong Y Microbes Infect; 2002 Feb; 4(2):175-82. PubMed ID: 11880049 [TBL] [Abstract][Full Text] [Related]
2. The molecular basis of antifolate resistance in Plasmodium falciparum: looking beyond point mutations. Heinberg A; Kirkman L Ann N Y Acad Sci; 2015 Apr; 1342(1):10-8. PubMed ID: 25694157 [TBL] [Abstract][Full Text] [Related]
3. Recombinant Plasmodium falciparum dihydrofolate reductase-based in vitro screen for antifolate antimalarials. Brobey RK; Sano G; Itoh F; Aso K; Kimura M; Mitamura T; Horii T Mol Biochem Parasitol; 1996 Oct; 81(2):225-37. PubMed ID: 8898337 [TBL] [Abstract][Full Text] [Related]
4. Mechanisms of resistance of malaria parasites to antifolates. Gregson A; Plowe CV Pharmacol Rev; 2005 Mar; 57(1):117-45. PubMed ID: 15734729 [TBL] [Abstract][Full Text] [Related]
6. Modelling and informatics in the analysis of P. falciparum DHFR enzyme inhibitors. Adane L; Bharatam PV Curr Med Chem; 2008; 15(16):1552-69. PubMed ID: 18673224 [TBL] [Abstract][Full Text] [Related]
7. Similar trends of pyrimethamine resistance-associated mutations in Plasmodium vivax and P. falciparum. Alam MT; Bora H; Bharti PK; Saifi MA; Das MK; Dev V; Kumar A; Singh N; Dash AP; Das B; Wajihullah ; Sharma YD Antimicrob Agents Chemother; 2007 Mar; 51(3):857-63. PubMed ID: 17194833 [TBL] [Abstract][Full Text] [Related]
10. Antifolate resistance due to new and known Plasmodium falciparum dihydrofolate reductase mutations expressed in yeast. Cortese JF; Plowe CV Mol Biochem Parasitol; 1998 Aug; 94(2):205-14. PubMed ID: 9747971 [TBL] [Abstract][Full Text] [Related]
11. Exploiting structural analysis, in silico screening, and serendipity to identify novel inhibitors of drug-resistant falciparum malaria. Dasgupta T; Chitnumsub P; Kamchonwongpaisan S; Maneeruttanarungroj C; Nichols SE; Lyons TM; Tirado-Rives J; Jorgensen WL; Yuthavong Y; Anderson KS ACS Chem Biol; 2009 Jan; 4(1):29-40. PubMed ID: 19146480 [TBL] [Abstract][Full Text] [Related]
12. Mutations associated with sulfadoxine-pyrimethamine and chlorproguanil resistance in Plasmodium falciparum isolates from Blantyre, Malawi. Alker AP; Mwapasa V; Purfield A; Rogerson SJ; Molyneux ME; Kamwendo DD; Tadesse E; Chaluluka E; Meshnick SR Antimicrob Agents Chemother; 2005 Sep; 49(9):3919-21. PubMed ID: 16127071 [TBL] [Abstract][Full Text] [Related]
13. Malarial (Plasmodium falciparum) dihydrofolate reductase-thymidylate synthase: structural basis for antifolate resistance and development of effective inhibitors. Yuthavong Y; Yuvaniyama J; Chitnumsub P; Vanichtanankul J; Chusacultanachai S; Tarnchompoo B; Vilaivan T; Kamchonwongpaisan S Parasitology; 2005 Mar; 130(Pt 3):249-59. PubMed ID: 15796007 [TBL] [Abstract][Full Text] [Related]
14. Inhibitors of de novo folate enzymes in Plasmodium falciparum. Nzila A Drug Discov Today; 2006 Oct; 11(19-20):939-44. PubMed ID: 16997145 [TBL] [Abstract][Full Text] [Related]
15. Ordered accumulation of mutations conferring resistance to sulfadoxine-pyrimethamine in the Plasmodium falciparum parasite. Mita T; Ohashi J; Venkatesan M; Marma AS; Nakamura M; Plowe CV; Tanabe K J Infect Dis; 2014 Jan; 209(1):130-9. PubMed ID: 23922363 [TBL] [Abstract][Full Text] [Related]
16. Homology modeling of wild type and pyrimethamine/cycloguanil-cross resistant mutant type Plasmodium falciparum dihydrofolate reductase. A model for antimalarial chemotherapy resistance. Santos-Filho OA; de Alencastro RB; Figueroa-Villar JD Biophys Chem; 2001 Jul; 91(3):305-17. PubMed ID: 11551441 [TBL] [Abstract][Full Text] [Related]
17. Identification of the optimal third generation antifolate against P. falciparum and P. vivax. Hunt SY; Detering C; Varani G; Jacobus DP; Schiehser GA; Shieh HM; Nevchas I; Terpinski J; Sibley CH Mol Biochem Parasitol; 2005 Dec; 144(2):198-205. PubMed ID: 16181688 [TBL] [Abstract][Full Text] [Related]
18. Preclinical evaluation of the antifolate QN254, 5-chloro- N'6'-(2,5-dimethoxy-benzyl)-quinazoline-2,4,6-triamine, as an antimalarial drug candidate. Nzila A; Rottmann M; Chitnumsub P; Kiara SM; Kamchonwongpaisan S; Maneeruttanarungroj C; Taweechai S; Yeung BK; Goh A; Lakshminarayana SB; Zou B; Wong J; Ma NL; Weaver M; Keller TH; Dartois V; Wittlin S; Brun R; Yuthavong Y; Diagana TT Antimicrob Agents Chemother; 2010 Jun; 54(6):2603-10. PubMed ID: 20350951 [TBL] [Abstract][Full Text] [Related]